Abstract
Clinical criteria for the diagnosis of dementia of the Alzheimer type (DAT) vary considerably in the current literature (1–4). Most investigators develop uniform criteria in order to be certain of homogeneity within a given cohort of patients for research purposes. Restricted criteria can lead to refinement in diagnosis, particularly when supported by careful postmortem verification (4–6). In view of this, several investigations are currently in progress to develop both qualitative and quantitative clinical and diagnostic measures for use in DAT.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Eisendorfer C, Cohen D: Diagnostic criteria for primary neuronal degeneration of the Alzheimer type. J Fam Pract 1980; 2: 553–7.
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RD: A new clinical scale for the staging of dementia. Brit J Psychiat 1982; 140: 566–72.
Berg L, Hughes CP, Coben LA, Danziger WL, Martin RL, Knesevich J: Mild senile dementia of the Alzheimer type: Research diagnostic criteria,recruitment and description of a study population. J Neurol Neurosurg Psychiat 1982; 45: 962–8.
Todorov AB, Go RCP, Constantinidis J, Elston RC: Specificity of the clinical diagnosis of dementia. J Neurol Sci 1975; 26: 81–98.
Ron MA, Toone BK, Graralda ME, Lishroan WA: Diagnostic Accuracy in presenile dementia. Brit J Psychiat 1979: 161–8.
Sulka R, Matti H, Paetan A, Wikstom J, Palo J: Accuracy of clinical diagnosis in primary degenerative donentia: Correlation with neuropathological findings. J Neurol Neurosurg Psychiat 1983; 46: 9–13.
Crystal HA, Horoupian DS, Katzman R, Jotkowitz S: Biopsy-proven Alzheimer disease presenting as a right parietal lobe syndrome. Ann Neurol 1982; 12: 186–8.
Bird TD, stranahan S, Sumi M, Raskind M: Alzheimer’s disease and choline acetyltransferase activity in brain tissue from clinical and pathological subgroups. Ann Neurol 1983; 14: 284–93.
Jacob H: Muscular twitching in Alzheimer’s disease. In: Wolstenholme GEW, O’Conner M, eds. Alzheimer’s disease and related ccnditions. London: Churchill. 1970: 75–93.
Faden AL, Townsoid JJ: myoclonus in Alzheimer’s disease. Arch Neurol 1976; 33: 278–80.
Mayeux R, Hunter S, Fahn S: More on myoclonus in Alzheimer’s disease. Ann Neurol 1980; 8: 200.
Pearce J: The extrapyramidal disorder of Alzheimer’s disease. Europ Neurol 1974; 12: 94–103.
Molsa PK, Martilla R, Rinne UK: Extrapyramidal signs in Alzheimer’s disease. Neurology 1984; 34: 1114–6.
Leverenz J, Sumi SM: Prevalence of Parkinson’s disease in patients with Alzheimer’s disease. Neurology 1984; 34: 101.
American Psychiatric Associationr Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Washington, D.C. 1980, pp. 205–24.
Hachinski VC, Iliff ID, Zhilka E, duBoulay GHD, McAllister VC, Marshall J, Russell RWR, Syinon L: Cerebral blood flow in dementia. Arch Neurol 1975; 32: 632–7.
Lesser RP, Fahn S, Shider SR, Cote LJ, Isgreoi WP, Barrett RE: Analysis for the clinical problenns in parkinsonism and the complications of long-term levodopa therapy. Neurology 1979; 29: 1253–60.
Blessed G, Tomlinson BE, Roth M: ihe association between quantitative measures of dementia and of senile changes in the cerdDral grey matter of elderly subjects. Brit J Psychiat 1968; 225: 797–811.
Folstein MF, Folstein SE, McHugh PR: “Mini-Mental State” a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–98.
Mayeux R, Stem Y, Rosen J, Leventhal J: Depression, intellectual iirpairment and Parkinson’s disease. Neurolocrv 1981; 31: 645–50.
Overall JE, Groham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10: 799 - 812.
Rosenblum WI, Ghatak NR: Lewy bodies in the presence of Alzheimer’s disease. Arch Neurol 1979: 36: 170–1.
Perl DP, Pendlebury WW, Bird ED: Detailed neuropathological evaluation of banked brain specimens submitted with a clinical diagnosis of Alzheimer’s disease. In: Wurtman RJ, Corkin SH, Growdon JH, eds. Alzheioner’s Disease: Advances in Basic Research and Therapies. Center for Brain Scioices and Metabolism Charitable Trust: Zurich, 1984: 463.
Alvord EC: The pathology of parkinsonism: etiologic, pathogenetic and pronostic implications. Trans Am Neurol Assoc 1965; 90: 167–8.
Alvord EC, Forno LS, Kusske JA, Kauffman RJ, Rhodes JS, Goetowski CR: The pathology of parkinsaiism: A coirparison of degeneration in the cerebral; cortex and brain stem. Adv Neurol 1975; 5: 175–93.
Hakim AM, Mathieson G: Dementia in Parkinson disease: A neuropathologic study. Neurology 1979; 29: 1209–14.
Boiler F, Mizutani T, Roessmann V, Gambetti P: Parkinson disease, dementia, and Alzheimer disease: Clinicopathological correlations. Ann Neurol 1980; 1: 329–35.
Whitdiouse P, Hedreai JC White C, DeLong M, Price DL: Basal forebrain neurons in the dementia of Parkinson’s disease. Ann Neurol 1983; 13: 243–8.
Ruberg M, Ploska A, Javoy-Agid F, Agid Y: Muscarinic binding and choline acetyltransferase activity in parkinsonian subjects with reference to denaitia. Brain Res 1982; 232: 129–33.
Perry RH, Tomlinsai BE, Candy JM, Blessed G, Foster JF, Blaxham CA, Perry E: Cortical cholinergic deficit in mentally impaired parkinsonian patients. Lancet 1983; 309: 789–90.
Mayeux R, Stern Y, Rosen J, Benson DF: Is subcortical dementia a recognizable clinical entity? Ann Neurol 1983; 14: 278–83.
Krai VA: Benign Senescent forgetfulness. In: Katzman R, Terry RD, Bick KL, eds. Alzheimer’s disease: Senile dementia and related disorders. New York: Raven Press, 1978: 47–51.
Tagliavini F, Pilleri G: Neuronal counts in basal nucleus of Meynert in Alzheimer disease and in simple senile dementia. Lancet 1983; 1: 469–70.
Berg L, Danziger WL, Storandt M, Coben LA, Gado M, Hughes CP, Knesevich JW, Botwinick J: Predictive features in mild soiile dementia of the Alzheimer type. Neurology 1984; 34: 563–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Mayeux, R., Stern, Y. (1986). Clinical Heterogeneity in Patients with Dementia of the Alzheimer Type. In: Fisher, A., Hanin, I., Lachman, C. (eds) Alzheimer’s and Parkinson’s Disease. Advances in Behavioral Biology, vol 29. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2179-8_16
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2179-8_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9283-8
Online ISBN: 978-1-4613-2179-8
eBook Packages: Springer Book Archive